1Ray R, Lambert JR. 1 c, 25-Dihydroxyvitamin D3 -3[3-bro- moacetate, a potential cancer therapeutic agent: synthesis and molecular mechanism of action [ J ]. Bioorg Med Chem Lett, 2011, 21 (8) : 2537 - 2540.
2Colston KW. Vitamin D and breast cancer risk [ J ]. Best Pract Res Clin Endocrinol Metab, 2008, 22 (4): 587-599.
3Marchionatti AM, Picotto G, Narvaez C J, et al. Antiprolif- erative action of menadione and 1, 25 (OH) 2 D3 on breast cancer cells [J]. J Steroid Biochem Mol Biol, 2009, 113 (3 -5):227 -232.
4Tse AK, Zhu GY, Wan Ck, et al. l alpha, 25-Di- hydroxyvitamin D3 inhibits transcriptional potential of nu- clear factor kappa B in breast cancer ceils [ J ]. Mol Im- munol. 2010. 47 (9): 1728 - 1738.
5Welsh J. Vitamin D metabolism in mammary gland and breast cancer [J]. Mol Cell Endocrinol, 2011, 347 (1 - 2):55 -60.
6Lundqvist J, Norlin M, Wikvall K. lc, 25-Dihydroxyvita- min D3 exerts tissue-specific effects on estrogen and andro- gen metabolism [J]. Biochim Biophys Acta, 2011, 1811 ( 4 ) : 263 - 270.
7Karlsson S, Olausson J, Lundh D, et al. Vitamin D and prostate caner: the role of membrane initiated signaling pathways in prostate eaneer progression [ J ] J Steroid Bioehem Mol Biol, 2010, 121 (1 -2):413 -416.
8Schwartz GG. Vitamin D and intervention trials in prostate cancer: from theory to therapy [ J]. Ann Epidemiol, 2009, 19 (2):96-102.
9Bao BY, Ting HJ, Hsu JW, et al. Down-regulation of NF- kappaB signals is involved in loss of l alpha, 25-di- hydroxyvitamin D3 responsiveness [ J ]. J Steroid Biochem MolBiol, 2010, 120 (1):11-21.
10Gavrilov V, Leibovich Y, Ariad S, et al. A combined pre- treatment of 1,25-dihydroxyvitamin D3 and sodium val- proate enhances the damaging effect of ionizing rediation on prostate cancer cells [ J]. J Steroid Biochem Mol Biol, 2010, 121 (1-2):391-394.
5Holick MF. Resurrection of vitamin D deficiency and rick- ets[J]. J Clin Invest ,2006,116(8) : 2062-2072.
6Holick MF. Vitamin D deficieney[J]. N Engl J Med, 2007, 357(3) :266-281.
7Woo J, Lam CW, Leung J, et al. Very high rates of vita- min D insufficiency in women of child-bearing age living in Beijing and Hong Kong[J]. Br J Nutr, 2008,99 (6) : 1330-1334.
8Kim CJ. Vitamin D dependent rickets type I [J]. Korean J Pediatr,2011,54(2) : 51-54.
9Marwaha RK, Tandon N, Reddy DR,et al. Vitamin D and bone mineral density status of healthy schoolchildren in northern India[J]. Am J Clin Nutr,2005,82(2) :477 482.
10Lawenda BD.Kelly KM,Ladas EJ.et al.Should supplemental an-tioxidant administration he avoided during chemotherapy and ra-diation therapy[J].J Natl Cancer Inst,2008,100(11):773-783.
